APA

Nazha S., Tanguay S., Kapoor A., Jewett M., Kollmannsberger C., Wood L., Bjarnason G. A. G., Heng D., Soulières D., Reaume M. N., Basappa N., Lévesque E. & Dragomir A. (20190109). Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence. : Clinical drug investigation.

Chicago

Nazha Sara, Tanguay Simon, Kapoor Anil, Jewett Michael, Kollmannsberger Christian, Wood Lori, Bjarnason G A Georg, Heng Daniel, Soulières Denis, Reaume Martin Neil, Basappa Naveen, Lévesque Eric and Dragomir Alice. 20190109. Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence. : Clinical drug investigation.

Harvard

Nazha S., Tanguay S., Kapoor A., Jewett M., Kollmannsberger C., Wood L., Bjarnason G. A. G., Heng D., Soulières D., Reaume M. N., Basappa N., Lévesque E. and Dragomir A. (20190109). Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence. : Clinical drug investigation.

MLA

Nazha Sara, Tanguay Simon, Kapoor Anil, Jewett Michael, Kollmannsberger Christian, Wood Lori, Bjarnason G A Georg, Heng Daniel, Soulières Denis, Reaume Martin Neil, Basappa Naveen, Lévesque Eric and Dragomir Alice. Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence. : Clinical drug investigation. 20190109.